MOHAMED OTHMAN to Receptor, ErbB-2
This is a "connection" page, showing publications MOHAMED OTHMAN has written about Receptor, ErbB-2.
Connection Strength
0.648
-
The MiR-200c/FOXP3 Network: A Promising Biomarker for Predicting Trastuzumab Response in HER2-Positive Breast Cancer. Technol Cancer Res Treat. 2024 Jan-Dec; 23:15330338241292226.
Score: 0.648